These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


161 related items for PubMed ID: 8831253

  • 1. Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias.
    Pini M, Scoditti U, Caliumi F, Manotti C, Quintavalla R, Pattacini C, Poli T, Tagliaferri A, di Iasio MG, Bernardi F.
    Recenti Prog Med; 1996; 87(7-8):331-7. PubMed ID: 8831253
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oral contraceptive risks: a realistic appraisal.
    Bressler R, Durand JL.
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F.
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Thromboembolic attacks in the central nervous system and P-pills].
    Lidegaard O.
    Ugeskr Laeger; 1982 Sep 20; 144(38):2769-72. PubMed ID: 7157502
    [Abstract] [Full Text] [Related]

  • 11. Thromboembolism during hormone therapy in Japanese women.
    Adachi T, Sakamoto S.
    Semin Thromb Hemost; 2005 Jun 20; 31(3):272-80. PubMed ID: 16052396
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
    Rekers H, Norpoth T, Michaels MA.
    Eur J Contracept Reprod Health Care; 1996 Jun 20; 1(1):21-30. PubMed ID: 9678134
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral contraceptives and thrombotic disease: risk of venous thromboembolism.
    Helmerhorst FM, Bloemenkamp KW, Rosendaal FR, Vandenbroucke JP.
    Thromb Haemost; 1997 Jul 20; 78(1):327-33. PubMed ID: 9198174
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.